BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22108199)

  • 1. EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma.
    Li Z; Chen X; Li L; Liu S; Yang L; Ma X; Tang M; Bode AM; Dong Z; Sun L; Cao Y
    Int J Biochem Cell Biol; 2012 Feb; 44(2):275-9. PubMed ID: 22108199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
    Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
    Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr Virus miR-BHRF1-3 Targets the BZLF1 3'UTR and Regulates the Lytic Cycle.
    Fachko DN; Chen Y; Skalsky RL
    J Virol; 2022 Feb; 96(4):e0149521. PubMed ID: 34878852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers.
    Tsai MH; Lin X; Shumilov A; Bernhardt K; Feederle R; Poirey R; Kopp-Schneider A; Pereira B; Almeida R; Delecluse HJ
    Oncotarget; 2017 Feb; 8(6):10238-10254. PubMed ID: 28052012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma.
    Lei T; Yuen KS; Xu R; Tsao SW; Chen H; Li M; Kok KH; Jin DY
    Int J Cancer; 2013 Jul; 133(1):79-87. PubMed ID: 23280823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of the expression of the Epstein-Barr virus (EBV) anti-apoptotic gene BHRF1 in nasopharyngeal carcinoma and EBV-related lymphoid diseases.
    Nicholls J; Kremmer E; Meseda CA; Mackett M; Hahn P; Gulley ML; Brink A; Swinnen LJ; Greenspan J; De Souza Y; Grässer F; Sham J; Ng MH; Arrand JR
    J Med Virol; 2001 Sep; 65(1):105-13. PubMed ID: 11505451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.
    He B; Li W; Wu Y; Wei F; Gong Z; Bo H; Wang Y; Li X; Xiang B; Guo C; Liao Q; Chen P; Zu X; Zhou M; Ma J; Li X; Li Y; Li G; Xiong W; Zeng Z
    Cell Death Dis; 2016 Sep; 7(9):e2353. PubMed ID: 27584792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of Epstein-Barr virus BHRF1 gene, a homologue of bcl-2.
    Jing YZ; Wang Y; Jia YP; Luo B
    Chin J Cancer; 2010 Dec; 29(12):1000-5. PubMed ID: 21114920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.
    Amoroso R; Fitzsimmons L; Thomas WA; Kelly GL; Rowe M; Bell AI
    J Virol; 2011 Jan; 85(2):996-1010. PubMed ID: 21068248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus.
    Li J; Callegari S; Masucci MG
    PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.
    Xing L; Kieff E
    J Virol; 2007 Sep; 81(18):9967-75. PubMed ID: 17626073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.